Galvanize Therapeutics
Galvanize Therapeutics: Global leader in energy-based medical technology for diverse healthcare solutions.
- 122
- Company
- Redwood City, CA, USUnited States
Galvanize Therapeutics: Global leader in energy-based medical technology for diverse healthcare solutions.
galvanizetx.comCrawled Oct 14, 2026
Galvanize Therapeutics develops pulsed electric field technology for oncology and chronic disease. The page introduces its leadership team and describes how the company was formed.
Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.
Galvanize Therapeutics' page explains how it collects, uses, and discloses information on galvanizetx.com, including cookies, third-party analytics, and user choices.
Galvanize Therapeutics presents exploratory evidence indicating Aliya PEF Energy, an electric field-based cancer treatment, may also activate the immune system to combat disease. The findings suggest broader therapeutic potential beyond tumor targeting. Research focuses on Aliya’s ability to modulate immune responses, though results remain in early-stage exploration.
Aug 2026sofinnovapartners.comNews article
Galvanize Therapeutics completes the first commercial procedures with its FDA-cleared **Aliya EX system**, a medical device for interventional applications. The milestone follows regulatory clearance, marking the system’s transition from clinical testing to real-world patient use. No specific procedural details or customer names are disclosed in the announcement.
Aug 2026Interventional NewsNews article
Galvanize Therapeutics secures FDA clearance for its **Aliya EX Generator**, expanding its **Aliya pulsed electric field (PEF) platform** for **surgical ablation of soft tissue**. The company specializes in PEF therapies for oncology applications, targeting precise tissue treatment during procedures. This clearance broadens its portfolio of medical devices for minimally invasive tumor ablation.
May 2026PR NewswireNews article
Galvanize Therapeutics secures $100 million in funding to advance its pulsed electric field technology. The company also names Doug Godshall, former CEO of Shockwave Medical, as its new chair and CEO. This marks a leadership transition aimed at scaling therapeutic innovations in the medical device sector.
Sep 2025MassDeviceNews article